The Diagnostics and Research Tools Partnering Conference DxPx will be held from 17th to 21st Nov this year, featuring over 380 participants from 25 countries for One-to-One meetings, industry talks of renowned speakers and pitches from the up-and-coming growth companies.
Thanks to the support of our sponsors Convergence Partners, MyBioGate and many other partners over 40 Chinese investors are taking part in DxPx for China forum, one-to-one meetings and pitches, which makes us one of the best partnering platform for Chinese investors to bring international diagnostics companies to China market. Some of the participating investors and corporates with China Focus: |

Sponsors of China Focus@DxPx .

Other Investors .
- AriMed advisors Ltd
- BeiGene
- Beijing Enterprises Healthcare industry fund
- Beijing Hongshan Investment Management
- BGI
- Capitallink
- Clinical Service Center
- Gemseki
- Genscript
- Golden Biotechnology Corporation
- Goldman Sachs
- Jounce Therapeutics
- Innovation Center of High Performace Dedical Mevice
- Langsheng investment
- Luhe Capital
- Luoxin Pharma
- Morningside ventures
- Prxima Ventures
- Qiming Venture Partners
- QIRUN BIOTECH CO.LTD.
- Topwin Group
- Shanghai FOSUN Pharma Group Co. Ltd
- Shanghai Joyin Enterprise Management Co. Ltd
- Shanghai Xudong Haipu Pharmaceutical
- Vigintillion Capital
- WI Harper
How to find Chinese and many many more investors at DxPx?
- Effective, pre-scheduled One-to-One meetings with all participating investors. Limited time slots!
- China Forum Pitch (8 slots)
-
- Apply for your 30 minutes live pitch to Chinese investors
- Maximal exposure with our China Focus@DxPx promotions
- Virtual exhibition booth
- Chatroom with pitch video remains opened after DxPx